DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality
Viral infections represent a major threat to human health and the global economy; however, most of the currently
available antiviral drugs are not fully effective in restricting viral replication and selecting for drug-resistant variants.
Targeted protein degradation technologies are promising strategies to avoid or delay the emergence of drug
resistance. Among the protein degradation-based multi-specific approaches, proteolysis targeting chimera (PROTAC)
is the main strategy applied in the antiviral field. In this review we will introduce the elements and mechanisms of
action used by PROTAC technology, as well as the advantages of PROTACs over available antiviral drugs. We also
summarize the latest progress in the application of PROTACs in antiviral research, discuss existing challenges and
look into future opportunities for antiviral drug discovery, We gratefully acknowledge financial support from the National
Natural Science Foundation of China (NSFC No. 82173677) and
the Science Foundation for Outstanding Young Scholars of
Shandong Province (ZR2020JQ31). This work was supported, in
part, by the Ministry of Science and Innovation of Spain through
grant PID2019-104176RB-I00/AEI/10.13039/501100011033
awarded to L.M.-A. N.L.-C. is supported by a contract (PEJ2020-AI/BMD-19429) of the Youth Guarantee programme of
the European Union with the participation of the Comunidad
de Madrid (Consejería de Educación, Universidades, Ciencia y
Portavocía). An institutional grant of the Fundación Ramón
Areces to the CBMSO is also acknowledged. The team at
CBMSO is affiliated to the Global Virus Network, Peer reviewed